Clinical Trial Update: Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vitamin D to reduce risk and severity of COVID-19 and other acute respiratory infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infection

Snippet

Sponsor: Queen Mary University of London | Conditions: Covid19, Acute Respiratory Tract Infection | Phase 3 | Status: COMPLETED